EUVIMEDEUVIMED entdecken
Crossref

Matrine Protects Endothelial Progenitor Cells against Apoptosis and Promotes Their Migration, Invasion, and Tube Formation Abilities via Modulating miR-126b/FOXO4 Axis

Xiqi Zhu, Jian Jiang, Jian Wang, Zhiyin Zhou, Xiaoming Ge

Pharmacology · 2023

DOI: 10.1159/000527812 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, 2023. Verfasst von Xiqi Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Wuxi Second People's Hospital, Wuxi, China. Hauptthemen laut MEDLINE: Endothelial Progenitor Cells, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction and Objective: Endothelial progenitor cells (EPCs) have been proven to exhibit a therapeutic effect in deep vein thrombosis, but are susceptible to microenvironment. Besides, Matrine has promotive effects on EPCs, but its effects on microRNA (miR)-126 remain obscure, which are therefore discussed in the study.

Methods

The cultured EPCs were extracted from Sprague-Dawley rats and identified by immunofluorescence assay. After being treated with Matrine or transfected with miR-126b inhibitor and small interfering RNA targeting forkhead box (FOXO) 4, the viability and apoptosis of EPCs were determined by cell counting kit-8 assay and flow cytometry. The migration, invasion, and tube formation abilities were detected by scratch, Transwell, and tube formation assays. The target genes of miR-126b were predicted by TargetScan, and verified by dual-luciferase reporter assay. The expressions of miR-126b, FOXO4, matrix metalloproteinase (MMP) 2, MMP9, and vascular endothelial growth factor (VEGF) A were determined by quantitative real-time polymerase chain reaction and Western blot.

Results

The EPCs were successfully extracted and cultured, as evidenced by positive reaction cluster of differentiation (CD) 34 and CD133. Matrine promoted the viability, migration, invasion, and tube formation while inhibiting the apoptosis of EPCs, and upregulated the expression of miR-126b. Besides, miR-126b inhibitor reversed the effects of Matrine on EPCs and downregulated the expression levels of MMP2, MMP9, and VEGFA. MiR-126b targeted the FOXO4, and siFOXO4 reversed the abovementioned effects of miR-126b inhibitor on EPCs.

Conclusion

Matrine protects EPCs from apoptosis and promotes their migration, invasion, and tube formation abilities via regulating miR-126b/FOXO4 axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endothelial Progenitor CellsMicroRNAsRatsAnimalsVascular Endothelial Growth Factor AMatrinesMatrix Metalloproteinase 9Rats, Sprague-DawleyApoptosisCell MovementCell ProliferationForkhead Transcription Factors

Stichwörter der Autor:innen

Deep vein thrombosisEndothelial progenitor cellsForkhead box 4MatrinemicroRNA-126b

Substanzen

MicroRNAsVascular Endothelial Growth Factor AMatrinesMatrix Metalloproteinase 9FOXO4 protein, ratForkhead Transcription Factors

Autor:innen und Institutionen

  • Department of Vascular Surgery, Wuxi Second People's Hospital, Wuxi, China.
  • Department of General Surgery, Wuxi Second People's Hospital, Wuxi, China.

Zitieren

APA

Zhu, X., Jiang, J., Wang, J., Zhou, Z., & Ge, X. (2023). Matrine Protects Endothelial Progenitor Cells against Apoptosis and Promotes Their Migration, Invasion, and Tube Formation Abilities via Modulating miR-126b/FOXO4 Axis. Pharmacology. https://doi.org/10.1159/000527812

Vancouver

Zhu X, Jiang J, Wang J, Zhou Z, Ge X. Matrine Protects Endothelial Progenitor Cells against Apoptosis and Promotes Their Migration, Invasion, and Tube Formation Abilities via Modulating miR-126b/FOXO4 Axis. Pharmacology. 2023. doi:10.1159/000527812

BibTeX
@article{Zhu2023,
  author = {Zhu, Xiqi and Jiang, Jian and Wang, Jian and Zhou, Zhiyin and Ge, Xiaoming},
  title = {Matrine Protects Endothelial Progenitor Cells against Apoptosis and Promotes Their Migration, Invasion, and Tube Formation Abilities via Modulating miR-126b/FOXO4 Axis},
  journal = {Pharmacology},
  year = {2023},
  doi = {10.1159/000527812}
}
Kostenlos starten →